Skip to main content
DuChemBio Co, LTD logo

DuChemBio Co, LTD — Investor Relations & Filings

Ticker · 176750 ISIN · KR7176750008 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2025-03-14 AGM Information
Country KR South Korea
Listing KO 176750

About DuChemBio Co, LTD

http://www.duchembio.com/en/

DuChemBio Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of radiopharmaceuticals. The company focuses on products for both diagnosis and treatment, with a primary emphasis on positron emission tomography (PET) imaging tracers. Its portfolio targets key therapeutic areas, including oncology for cancer detection and neurology for conditions such as Alzheimer's and Parkinson's disease. The company's mission is to develop novel radiopharmaceuticals and achieve successful commercialization on a global scale.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by DuChemBio. It outlines the date, location, and agenda items (such as approval of financial statements, articles of incorporation changes, and director compensation). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2025-03-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to previously granted stock options, including adjustments to the number of recipients and the total number of shares granted. In the context of financial filings, announcements regarding stock option grants, amendments, or capital structure changes that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified as general regulatory filings.
2025-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for DuchemBio. It contains the meeting agenda, details on voting, and management information including board activities and business overviews. While it contains management information, the primary purpose of this specific document is to provide shareholders with the necessary information and materials to vote at the upcoming Annual General Meeting. According to the provided definitions, documents sent to shareholders to provide information and request votes for meetings are classified as Proxy Solicitation & Information Statement (PSI).
2025-03-14 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for DuchemBio, which includes details on the meeting agenda, voting items, and management information. It is a formal regulatory filing in Korea (DART-style) that provides shareholders with the necessary information to vote on company matters. While it contains some management report elements, its primary purpose is to solicit votes and provide notice for the upcoming AGM, making it a Proxy Solicitation & Information Statement.
2025-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (DuChemBio) regarding a significant change in financial structure (30% or more change in revenue or profit). This is a standard disclosure requirement for listed companies in Korea, typically filed via the DART system. Since it provides specific financial highlights and performance metrics rather than a full annual report or a simple announcement of a report's availability, it falls under the category of general regulatory filings. FY 2024
2025-03-07 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a regulatory filing from DuChemBio announcing an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as the date, location, purpose, and contact information. While it mentions 'IR 자료게재' (IR material publication), the document itself is the formal notice of the event, not the presentation slides themselves. According to the 'Menu vs Meal' rule, this is a regulatory announcement regarding an event/report, fitting the RNS (Regulatory Filings) category as it is a standard corporate disclosure for an IR event.
2025-03-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.